recombinant igf-1 lr3 ISOkine® IGF-I Human, Animal-Free Protein – Ilex Life Sciences Heterologous expression of IGF-1/LR3 IGF-1

Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A

CEAAs are synthesized endogenously from carbon skeletons derived from metabolic intermediates, such as those produced during glycolysis and the citric acid cycle, or via transamination reactions involving existing AAs (Litwack 2018)

Only a relatively thick band of hair remains on the sides and back

le trans-N-(2-chloro-6-mthylphnyl)-2-[[[2-(3-cyanophnyl)cyclopropyl]carbonyl]amino]-6-benzothiazolecarboxamide

Dosagem GHK-CU por objetivo Dosagem padro por nvel Dosagem baseada no peso (referncia) Base: 1530 mcg/kg Na prtica: a maioria usa dose fixa (12 mg) Reconstituio frasco de 50 mg Opo mais usada: Adicionar: 2,5 mL Concentrao: 20 mg/mL Converso: Reconstituio frasco de 100 mg Padro mais prtico: Adicionar: 3,0 mL Concentrao: 33,3 mg/mL Converso: Frmula universal de clculo Funciona para qualquer frasco ou diluio